| Literature DB >> 30995506 |
Helen M Lazear1, John W Schoggins2, Michael S Diamond3.
Abstract
Type I interferons (IFNs) (IFN-α, IFN-β) and type III IFNs (IFN-λ) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune priming, anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and highlight gaps in understanding of the biology of type I and type III IFNs in health and disease.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30995506 PMCID: PMC6839410 DOI: 10.1016/j.immuni.2019.03.025
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745